The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Body height decreased 16
SANDOSTATIN LAR DEPOT Diabetes mellitus inadequate control 16
SANDOSTATIN LAR DEPOT Faeces pale 16
SANDOSTATIN LAR DEPOT Femur fracture 16
SANDOSTATIN LAR DEPOT Haematuria 16
SANDOSTATIN LAR DEPOT Head discomfort 16
SANDOSTATIN LAR DEPOT Hypercholesterolaemia 16
SANDOSTATIN LAR DEPOT Hyperphagia 16
SANDOSTATIN LAR DEPOT Mood altered 16
SANDOSTATIN LAR DEPOT Speech disorder 16
SANDOSTATIN LAR DEPOT Vertigo 16
SANDOSTATIN LAR DEPOT Visual acuity reduced 16
SANDOSTATIN Blood pressure diastolic increased 15
SANDOSTATIN Gait disturbance 15
SANDOSTATIN Oedema peripheral 15
SANDOSTATIN Urinary tract infection 15
SANDOSTATIN LAR DEPOT Abdominal mass 15
SANDOSTATIN LAR DEPOT Amnesia 15
SANDOSTATIN LAR DEPOT Bowel movement irregularity 15
SANDOSTATIN LAR DEPOT Cyst 15

Total Records: 2,045     Number of Pages: 103